In the May 26th issue of Cell, Nick et al. discuss the use of two mycobacteriophage isolates to treat a Cystic Fibrosis patient with a severe bacterial infection. As a result of the treatment, the patient improved sufficiently that they became eligible for a life-saving lung transplant.
News or Events
News
News